No Data
Allurion Technologies Shares Are Trading Lower After the Company Priced a $20 Million Public Offering.
Allurion Technologies Shares Are Trading Lower After the Company Priced a $20 Million Public Offering.
Allurion Technologies: Proceeds to Fund Clinical Trials, Comml Sales and R&D >ALUR
Allurion Technologies: Proceeds to Fund Clinical Trials, Comml Sales and R&D >ALUR
Allurion Technologies to Place 14.4M Shares at a Public Offering Price of $1.20 Per Share for Gross Proceeds of $17.3M >ALUR
Allurion Technologies to Place 14.4M Shares at a Public Offering Price of $1.20 Per Share for Gross Proceeds of $17.3M >ALUR
Express News | Allurion Announces Pricing of $20 Million Public Offering and Concurrent Private Placement
Top Midday Decliners
CNS Pharmaceuticals (CNSP) shares plunged more than 37% amid heavy trading Wednesday after the company said it priced a registered direct offering and warrants at $2.45 per share. Over 1.3 million sha
Express News | Allurion: Underwritten Public Offering of up to $20 Mln of Its Common Stock